MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 210 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $245,655 | +4.5% | 7,397 | -0.6% | 0.00% | 0.0% |
Q3 2022 | $235,000 | -2.1% | 7,440 | -5.6% | 0.00% | -50.0% |
Q2 2022 | $240,000 | +18.8% | 7,882 | +1.3% | 0.00% | +100.0% |
Q1 2022 | $202,000 | +57.8% | 7,782 | +23.8% | 0.00% | 0.0% |
Q4 2021 | $128,000 | +2.4% | 6,287 | -3.5% | 0.00% | 0.0% |
Q3 2021 | $125,000 | -19.9% | 6,518 | -7.6% | 0.00% | 0.0% |
Q2 2021 | $156,000 | -10.9% | 7,055 | +5.8% | 0.00% | -50.0% |
Q1 2021 | $175,000 | +400.0% | 6,666 | +260.3% | 0.00% | – |
Q4 2020 | $35,000 | +16.7% | 1,850 | +4.5% | 0.00% | – |
Q3 2020 | $30,000 | -25.0% | 1,770 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $40,000 | -4.8% | 1,770 | -60.0% | 0.00% | 0.0% |
Q3 2019 | $42,000 | -60.4% | 4,430 | -50.6% | 0.00% | -75.0% |
Q2 2019 | $106,000 | -32.9% | 8,960 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $158,000 | +1.3% | 8,960 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $156,000 | +16.4% | 8,960 | 0.0% | 0.01% | +33.3% |
Q3 2018 | $134,000 | – | 8,960 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brown Capital Management | 5,709,876 | $117,681,000 | 1.95% |
Piermont Capital Management Inc. | 118,909 | $2,451,000 | 0.78% |
ZEVIN ASSET MANAGEMENT LLC | 120,325 | $2,480,000 | 0.70% |
CONNORS INVESTOR SERVICES INC | 151,945 | $3,132,000 | 0.62% |
Randolph Co Inc | 107,200 | $2,209,000 | 0.49% |
NAPLES GLOBAL ADVISORS, LLC | 51,172 | $1,055,000 | 0.44% |
Boston Trust Walden Corp | 1,098,713 | $22,645,000 | 0.39% |
MCKINLEY CAPITAL MANAGEMENT LLC | 348,934 | $7,192,000 | 0.35% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 248,900 | $5,130,000 | 0.30% |
Cardinal Capital Management | 32,137 | $662,000 | 0.28% |